Dr. Yosuke Miyashita, MD

Dr. Miyashita practices at Seattle Children's Hospital in Seattle, Washington, part of Seattle Children's Hospital, Research Institute and Foundation.

Dr. Miyashita's NPI, 1609986421, was assigned on August 30, 2006. Dr. Miyashita graduated from WashU Medicine in 2003. Dr. Miyashita holds Washington license MD61320775.

Dr. Miyashita's primary practice is Seattle Children's Hospital, at 4800 Sand Point Way NE, PO Box C-5371, Seattle, WA 98105 in King County. The practice phone is (206) 987-2000.

Dr. Miyashita's primary practice is Seattle Children's Hospital in Seattle, Washington, part of Seattle Children's Hospital, Research Institute and Foundation. The medical group on file is University of Pittsburgh Physicians, Department of Radiology. Dmand AI also links Dr. Miyashita to 5 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Miyashita practices. Vendor and product names are available with a free account.

Pediatric nephrology is Dr. Miyashita's primary specialty in the NPI Registry, under taxonomy code 2080P0210X. Dr. Miyashita is board certified in pediatric nephrology by the American Board of Pediatrics. Dmand AI has Dr. Miyashita's licenses on file in 3 states: Washington, Alaska and Pennsylvania.

CMS data shows 12 Medicare services from Dr. Miyashita across 1 procedure code in 2020, all of them office visits, for 24 Medicare patients. Medicare paid $927 for them. Every service was in an office.

CMS counts 24 Medicare patients who saw Dr. Miyashita in 2024. The largest group is under 65, with 24 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. Their average risk score is 7.26, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Miyashita's median patient age at 13, with 41% women.

In 2024, Dr. Miyashita wrote 30 Medicare Part D claims. 93% of them were for generic drugs. CMS names the drug for 22 of them, across 2 drugs with 11 or more claims each, at $372 in total drug cost. In 2020, CMS named 81 claims across 5 drugs.

Dr. Miyashita accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Miyashita as offering telehealth.

Dmand AI links 14 papers to Dr. Miyashita, published from 2011 to 2021. 2011 was the busiest year, with 2. The most frequent topics are Hypertension, Antihypertensive Agents and Acute Kidney Injury. Dr. Miyashita has published most often in Curr Hypertens Rep. Dr. Miyashita's most frequent co-authors are Joseph T. Flynn, MD, Coral D. Hanevold, MD and Michael L. Moritz.

Dr. Miyashita graduated from WashU Medicine in 2003.

Dr. Miyashita is in network with 20 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.